,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1290045,23978,Comparative Toxicogenomics Database (CTD),Copper,D003300,Copper,https://ctdbase.org/detail.go?type=chem&acc=D003300,9110,MTMR4,https://ctdbase.org/detail.go?type=gene&acc=9110,,,9110,MTMR4,9606,Homo sapiens (human),[NSC 689534 binds to copper] which results in decreased expression of MTMR4 mRNA,,,PMID:20971185,https://www.ncbi.nlm.nih.gov/pubmed/20971185,20971185,,
1,1265432,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,4301,AFDN,https://ctdbase.org/detail.go?type=gene&acc=4301,,,4301,AFDN,10116,Rattus norvegicus (Norway rat),Cadmium chloride results in increased expression of AFDN mRNA,,,PMID:33453195,https://www.ncbi.nlm.nih.gov/pubmed/33453195,33453195,,
2,1291205,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,221037,JMJD1C,https://ctdbase.org/detail.go?type=gene&acc=221037,,,221037,JMJD1C,9986,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] affects the expression of JMJD1C mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
3,1291206,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,23210,JMJD6,https://ctdbase.org/detail.go?type=gene&acc=23210,,,23210,JMJD6,9986,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of JMJD6 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
4,1344975,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,10507,SEMA4D,https://ctdbase.org/detail.go?type=gene&acc=10507,,,10507,SEMA4D,10116,Rattus norvegicus (Norway rat),Vinclozolin results in decreased expression of SEMA4D mRNA,,,PMID:23034163,https://www.ncbi.nlm.nih.gov/pubmed/23034163,23034163,,
5,1344976,39676,Comparative Toxicogenomics Database (CTD),Vinclozolin,C025643,vinclozolin,https://ctdbase.org/detail.go?type=chem&acc=C025643,10505,SEMA4F,https://ctdbase.org/detail.go?type=gene&acc=10505,,,10505,SEMA4F,10116,Rattus norvegicus (Norway rat),Vinclozolin affects the expression of SEMA4F mRNA,,,PMID:19015723,https://www.ncbi.nlm.nih.gov/pubmed/19015723,19015723,,
6,1375255,53037,Toxin and Toxin Target Database (T3DB),"2,3,3',5,5',6-Hexachlorobiphenyl",T3D0554,"2,3,3',5,5',6-Hexachlorobiphenyl",http://www.t3db.ca/toxins/T3D0554,BE0000123,Estrogen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000123,P03372,Estrogen receptor,2099,ESR1,9606,Homo sapiens (human),Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590),,,PMID:16531984,https://www.ncbi.nlm.nih.gov/pubmed/16531984,16531984,,
7,1375256,68551,Comparative Toxicogenomics Database (CTD),Mianserin hydrochloride,D008803,Mianserin,https://ctdbase.org/detail.go?type=chem&acc=D008803,177514,UNC-82,https://ctdbase.org/detail.go?type=gene&acc=177514,,,177514,unc-82,6239,Caenorhabditis elegans,Mianserin results in decreased expression of UNC-82 mRNA,,,PMID:27217151,https://www.ncbi.nlm.nih.gov/pubmed/27217151,27217151,,
8,1366826,77999,Comparative Toxicogenomics Database (CTD),Rosiglitazone,D000077154,Rosiglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077154,200931,SLC51A,https://ctdbase.org/detail.go?type=gene&acc=200931,,,200931,SLC51A,9606,Homo sapiens (human),Rosiglitazone results in decreased expression of SLC51A mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
9,1506667,104810,Toxin and Toxin Target Database (T3DB),Barium Cation,T3D0109,Barium,http://www.t3db.ca/toxins/T3D0109,BE0000672,Potassium voltage-gated channel subfamily KQT member 1,http://www.t3db.ca/biodb/bio_entities/BE0000672,P51787,Potassium voltage-gated channel subfamily KQT member 1,3784,KCNQ1,9606,Homo sapiens (human),"Barium is a competitive potassium channel antagonist that blocks the passive efflux of intracellular potassium, resulting in a shift of potassium from extracellular to intracellular compartments. the intracellular translocation of potassium results in a decreased resting membrane potential, making the muscle fibers electrically unexcitable and causing paralysis. (A151)",,,PMID:15226366,https://www.ncbi.nlm.nih.gov/pubmed/15226366,15226366,,
10,1505431,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383,ICAM1,9606,Homo sapiens (human),HTS 466284 inhibits the reaction [glucose results in increased expression of ICAM1 protein]|isoangustone A inhibits the reaction [glucose results in increased expression of ICAM1 mrna]|glucose results in increased expression of ICAM1 mrna|isoangustone A inhibits the reaction [glucose results in increased expression of ICAM1 protein],,,PMID:21367880,https://www.ncbi.nlm.nih.gov/pubmed/21367880,21367880,,
11,1505432,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383,ICAM1,9606,Homo sapiens (human),Manganese chloride inhibits the reaction [glucose results in increased expression of ICAM1 protein],,,PMID:23329836,https://www.ncbi.nlm.nih.gov/pubmed/23329836,23329836,,
12,1506321,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,20249,SCD1,https://ctdbase.org/detail.go?type=gene&acc=20249,,,20249,Scd1,10114,Rattus,"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of SCD1 mRNA",,,PMID:34952357,https://www.ncbi.nlm.nih.gov/pubmed/34952357,34952357,,
13,1960345,11497983,Drug Gene Interaction database (DGIdb),Barasertib,,BARASERTIB,https://www.dgidb.org/drugs/ncit:C62502,,LCK,https://www.dgidb.org/genes/hgnc:6524,,,3932,LCK,9606,Homo sapiens (human),,,,,,,,
14,1960346,11497983,Drug Gene Interaction database (DGIdb),Barasertib,,BARASERTIB,https://www.dgidb.org/drugs/ncit:C62502,,AURKA,https://www.dgidb.org/genes/hgnc:11393,,,6790,AURKA,9606,Homo sapiens (human),,,,,,,,
15,1960347,11498992,IUPHAR/BPS Guide to PHARMACOLOGY,"P'-geranyl 3,5,8-trihydroxy-3-methyloctanate 8-diphosphate",3210,"P'-geranyl 3,5,8-trihydroxy-3-methyloctanate 8-diphosphate",https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3210,642,diphosphomevalonate decarboxylase,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=642,Q62967,Diphosphomevalonate decarboxylase,81726,Mvd,10116,Rattus norvegicus (Norway rat),Competitive,pIC50,5.7,PMID:16524256,https://www.ncbi.nlm.nih.gov/pubmed/16524256,16524256,,
16,1962282,11524144,Comparative Toxicogenomics Database (CTD),Dorsomorphin,C516138,dorsomorphin,https://ctdbase.org/detail.go?type=chem&acc=C516138,282566,LINC00515,https://ctdbase.org/detail.go?type=gene&acc=282566,,,282566,LINC00515,9606,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LINC00515 mrna|[nog protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LINC00515 mrna|[nog protein co-treated with panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LINC00515 mrna|[nog protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LINC00515 mrna|[nog protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LINC00515 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
17,1963137,11661695,BindingDB,"18-[6-(Piperidin-1-yl)hexyl]-8-thia-18-azatetracyclo[9.7.0.0^{2,7}.0^{12,17}]octadeca-1(11),2(7),3,5,12(17),13,15-heptaene",22986,"18-[6-(piperidin-1-yl)hexyl]-8-thia-18-azatetracyclo[9.7.0.0^{2,7}.0^{12,17}]octadeca-1(11),2(7),3,5,12(17),13,15-heptaene",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22986,2323,DNA ligase A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2323,P9WNV1,DNA ligase A,887354,ligA,83332,Mycobacterium tuberculosis H37Rv,,IC50 (nM),1.35e+4,DOI:10.1007/s00044-007-9052-5,https://doi.org/10.1007/s00044-007-9052-5,,10.1007/s00044-007-9052-5,
18,1990755,12970028,BindingDB,"3-Oxa-13,23-diazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tricosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaen-12-one",14180,"3-oxa-13,23-diazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tricosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaen-12-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14180,6817,Mitogen-activated protein kinase kinase kinase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6817,P80192,Mitogen-activated protein kinase kinase kinase 9,4293,MAP3K9,9606,Homo sapiens (human),,IC50 (nM),>10000,PMID:17266195|DOI:10.1021/jm051074u,https://www.ncbi.nlm.nih.gov/pubmed/17266195|https://doi.org/10.1021/jm051074u,17266195,10.1021/jm051074u,
19,1990756,12970028,BindingDB,"3-Oxa-13,23-diazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tricosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaen-12-one",14180,"3-oxa-13,23-diazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tricosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaen-12-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14180,50001795,Mitogen-activated protein kinase kinase kinase 11,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50001795,Q16584,Mitogen-activated protein kinase kinase kinase 11,4296,MAP3K11,9606,Homo sapiens (human),,IC50 (nM),1106,PMID:17266195|DOI:10.1021/jm051074u,https://www.ncbi.nlm.nih.gov/pubmed/17266195|https://doi.org/10.1021/jm051074u,17266195,10.1021/jm051074u,
20,1990757,13073350,BindingDB,"(1S,2R,4aS,6aS,6bR,10S,12aR,12bR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid",23197,"(1S,2R,4aS,6aS,6bR,10S,12aR,12bR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23197,2338,"Glycogen phosphorylase, muscle form",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2338,P00489,"Glycogen phosphorylase, muscle form",100008972,PYGM,9986,Oryctolagus cuniculus (rabbit),,IC50 (nM),9000,PMID:18517260|DOI:10.1021/jm8000949,https://www.ncbi.nlm.nih.gov/pubmed/18517260|https://doi.org/10.1021/jm8000949,18517260,10.1021/jm8000949,
21,1990758,13155595,Therapeutic Target Database (TTD),"1,8-Naphthyridin-4-ol, 7-methyl-2-propyl-",D01MOQ,"7-Methyl-2-propyl-[1,8]naphthyridin-4-ol",https://idrblab.net/ttd/data/drug/details/D01MOQ,T92072,Adenosine A1 receptor (ADORA1),https://idrblab.net/ttd/data/target/details/T92072,P30542,Adenosine receptor A1,134,ADORA1,9606,Homo sapiens (human),Inhibitor,,,,,,,
22,1990759,13351031,BindingDB,"4,5,6,7-Tetrahydro-benzo[D]isoxazol-3-OL",23185,"4,5,6,7-tetrahydro-1,2-benzoxazol-3-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23185,2337,D-amino-acid oxidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2337,P00371,D-amino-acid oxidase,397134,DAO,9823,Sus scrofa (pig),,IC50 (nM),>100000,PMID:18507366|DOI:10.1021/jm800200u,https://www.ncbi.nlm.nih.gov/pubmed/18507366|https://doi.org/10.1021/jm800200u,18507366,10.1021/jm800200u,
23,1990760,13393486,Therapeutic Target Database (TTD),Bis(6-hydroxybenzo[b]furan-2-yl)methanone,D03VAA,Bis(6-hydroxybenzo[b]furan-2-yl)methanone,https://idrblab.net/ttd/data/drug/details/D03VAA,T59102,Platelet-derived growth factor receptor beta (PDGFRB),https://idrblab.net/ttd/data/target/details/T59102,P09619,Platelet-derived growth factor receptor beta,5159,PDGFRB,9606,Homo sapiens (human),Inhibitor,,,,,,,
24,1990761,13393486,Therapeutic Target Database (TTD),Bis(6-hydroxybenzo[b]furan-2-yl)methanone,D03VAA,Bis(6-hydroxybenzo[b]furan-2-yl)methanone,https://idrblab.net/ttd/data/drug/details/D03VAA,T74312,Fms-like tyrosine kinase 3 (FLT-3),https://idrblab.net/ttd/data/target/details/T74312,P36888,Receptor-type tyrosine-protein kinase FLT3,2322,FLT3,9606,Homo sapiens (human),Inhibitor,,,,,,,
25,1990762,13394149,Drug Gene Interaction database (DGIdb),Sanguinarine sulfate,,SANGUINARINE SULFATE,https://www.dgidb.org/drugs/chembl:CHEMBL1565133,,RGS12,https://www.dgidb.org/genes/hgnc:9994,,,6002,RGS12,9606,Homo sapiens (human),,,,,,,,
26,1990697,16094676,IUPHAR/BPS Guide to PHARMACOLOGY,"3-Methyl-n-(1-oxy-3',4',5',6'-tetrahydro-2'h-(2,4'-bipyridine)-1'-ylmethyl)benzamide",8439,ABT-670,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8439,217,D4 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=217,P21917,D(4) dopamine receptor,1815,DRD4,9606,Homo sapiens (human),Full agonist,pKi,5.84,PMID:17149874,https://www.ncbi.nlm.nih.gov/pubmed/17149874,17149874,,
27,1990695,16118737,BindingDB,"Aminopyrimidine amide, 13b",26369,"4-methyl-3-N-(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-5-yl)-1-N-[3-(trifluoromethyl)benzene]benzene-1,3-dicarboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26369,507,Tyrosine-protein kinase Lck,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=507,P06239,Tyrosine-protein kinase Lck,3932,LCK,9606,Homo sapiens (human),,IC50 (nM),0.6,PMID:18321037|DOI:10.1021/jm7010996,https://www.ncbi.nlm.nih.gov/pubmed/18321037|https://doi.org/10.1021/jm7010996,18321037,10.1021/jm7010996,
28,1990696,16118737,BindingDB,"Aminopyrimidine amide, 13b",26369,"4-methyl-3-N-(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-5-yl)-1-N-[3-(trifluoromethyl)benzene]benzene-1,3-dicarboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26369,4919,Tyrosine-protein kinase JAK3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4919,P52333,Tyrosine-protein kinase JAK3,3718,JAK3,9606,Homo sapiens (human),,IC50 (nM),>25000,PMID:18321037|DOI:10.1021/jm7010996,https://www.ncbi.nlm.nih.gov/pubmed/18321037|https://doi.org/10.1021/jm7010996,18321037,10.1021/jm7010996,
29,1990689,16129800,Comparative Toxicogenomics Database (CTD),Oenothein B,C080077,oenothein B,https://ctdbase.org/detail.go?type=chem&acc=C080077,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,9606,Homo sapiens (human),Oenothein B results in increased expression of BAX protein,,,PMID:30452899,https://www.ncbi.nlm.nih.gov/pubmed/30452899,30452899,,
30,1990690,16129800,Comparative Toxicogenomics Database (CTD),Oenothein B,C080077,oenothein B,https://ctdbase.org/detail.go?type=chem&acc=C080077,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,9606,Homo sapiens (human),Oenothein B results in decreased expression of BCL2 protein,,,PMID:30452899,https://www.ncbi.nlm.nih.gov/pubmed/30452899,30452899,,
31,1990691,16129800,Comparative Toxicogenomics Database (CTD),Oenothein B,C080077,oenothein B,https://ctdbase.org/detail.go?type=chem&acc=C080077,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Oenothein B results in increased cleavage of CASP3 protein,,,PMID:30452899,https://www.ncbi.nlm.nih.gov/pubmed/30452899,30452899,,
32,1990692,16129800,Comparative Toxicogenomics Database (CTD),Oenothein B,C080077,oenothein B,https://ctdbase.org/detail.go?type=chem&acc=C080077,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842,CASP9,9606,Homo sapiens (human),Acetylcysteine inhibits the reaction [oenothein B results in increased cleavage of CASP9 protein],,,PMID:30452899,https://www.ncbi.nlm.nih.gov/pubmed/30452899,30452899,,
33,1990693,16129800,Comparative Toxicogenomics Database (CTD),Oenothein B,C080077,oenothein B,https://ctdbase.org/detail.go?type=chem&acc=C080077,4793,NFKBIB,https://ctdbase.org/detail.go?type=gene&acc=4793,,,4793,NFKBIB,9606,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [oenothein B results in decreased phosphorylation of NFKBIB protein]|oenothein B results in decreased phosphorylation of NFKBIB protein|acetylcysteine inhibits the reaction [oenothein B results in decreased phosphorylation of NFKBIB protein]|oenothein B inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIB protein],,,PMID:30452899,https://www.ncbi.nlm.nih.gov/pubmed/30452899,30452899,,
34,1990694,16129800,Comparative Toxicogenomics Database (CTD),Oenothein B,C080077,oenothein B,https://ctdbase.org/detail.go?type=chem&acc=C080077,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Oenothein B results in increased expression of PARP1 protein,,,PMID:30452899,https://www.ncbi.nlm.nih.gov/pubmed/30452899,30452899,,
35,1990707,16129800,Comparative Toxicogenomics Database (CTD),Oenothein B,C080077,oenothein B,https://ctdbase.org/detail.go?type=chem&acc=C080077,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,9606,Homo sapiens (human),Oenothein B results in decreased phosphorylation of RELA protein|[acetylcysteine co-treated with oenothein B] results in decreased phosphorylation of RELA protein|oenothein B inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [oenothein B results in decreased phosphorylation of RELA protein],,,PMID:30452899,https://www.ncbi.nlm.nih.gov/pubmed/30452899,30452899,,
36,1990708,16129800,Comparative Toxicogenomics Database (CTD),Oenothein B,C080077,oenothein B,https://ctdbase.org/detail.go?type=chem&acc=C080077,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,9606,Homo sapiens (human),Oenothein B inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]|oenothein B inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIB protein],,,PMID:30452899,https://www.ncbi.nlm.nih.gov/pubmed/30452899,30452899,,
37,1990709,16129800,Comparative Toxicogenomics Database (CTD),Oenothein B,C080077,oenothein B,https://ctdbase.org/detail.go?type=chem&acc=C080077,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157,TP53,9606,Homo sapiens (human),Oenothein B results in increased expression of TP53 protein,,,PMID:30452899,https://www.ncbi.nlm.nih.gov/pubmed/30452899,30452899,,
38,1990710,16129980,Drug Gene Interaction database (DGIdb),2-[[1-[4-[(E)-2-[4-[[4-[(E)-2-[4-[4-[(2-carboxyphenyl)diazenyl]-3-methyl-5-oxo-4H-pyrazol-1-yl]-2-sulfophenyl]ethenyl]-3-sulfophenyl]carbamoylamino]-2-sulfophenyl]ethenyl]-3-sulfophenyl]-3-methyl-5-oxo-4H-pyrazol-4-yl]diazenyl]benzoic acid,,CHEMBL:CHEMBL1092743,https://www.dgidb.org/drugs/chembl:CHEMBL1092743,,ENPP2,https://www.dgidb.org/genes/hgnc:3357,,,5168,ENPP2,9606,Homo sapiens (human),,,,,,,,
39,1990711,16131124,Comparative Toxicogenomics Database (CTD),"LHRH, acetyl-2-(2-naphthyl)-ala(1)-4-F-phe(2)-trp(3)-arg(6)-",C042020,"LHRH, acetyl-2-(2-naphthyl)-Ala(1)-4-F-Phe(2)-Trp(3)-Arg(6)-",https://ctdbase.org/detail.go?type=chem&acc=C042020,2796,GNRH1,https://ctdbase.org/detail.go?type=gene&acc=2796,,,2796,GNRH1,9544,Macaca mulatta (Rhesus monkey),"LHRH, acetyl-2-(2-naphthyl)-ala(1)-4-F-phe(2)-trp(3)-arg(6)- inhibits the reaction [GNRH1 protein results in increased secretion of LHB protein]|lhrh, acetyl-2-(2-naphthyl)-ala(1)-4-F-phe(2)-trp(3)-arg(6)- promotes the reaction [GNRH1 protein results in increased secretion of testosterone]",,,PMID:3323497,https://www.ncbi.nlm.nih.gov/pubmed/3323497,3323497,,
40,1990712,16131124,Comparative Toxicogenomics Database (CTD),"LHRH, acetyl-2-(2-naphthyl)-ala(1)-4-F-phe(2)-trp(3)-arg(6)-",C042020,"LHRH, acetyl-2-(2-naphthyl)-Ala(1)-4-F-Phe(2)-Trp(3)-Arg(6)-",https://ctdbase.org/detail.go?type=chem&acc=C042020,3972,LHB,https://ctdbase.org/detail.go?type=gene&acc=3972,,,3972,LHB,9544,Macaca mulatta (Rhesus monkey),"LHRH, acetyl-2-(2-naphthyl)-ala(1)-4-F-phe(2)-trp(3)-arg(6)- inhibits the reaction [GNRH1 protein results in increased secretion of LHB protein]|lhrh, acetyl-2-(2-naphthyl)-ala(1)-4-F-phe(2)-trp(3)-arg(6)- results in decreased expression of LHB protein",,,PMID:3323497,https://www.ncbi.nlm.nih.gov/pubmed/3323497,3323497,,
41,1990713,16131438,IUPHAR/BPS Guide to PHARMACOLOGY,Humanin,1047,humanin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1047,223,FPR2/ALX,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=223,P25090,N-formyl peptide receptor 2,2358,FPR2,9606,Homo sapiens (human),Full agonist,pEC50,8.46,PMID:15465011,https://www.ncbi.nlm.nih.gov/pubmed/15465011,15465011,,
42,1990714,16131438,IUPHAR/BPS Guide to PHARMACOLOGY,Humanin,1047,humanin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1047,223,FPR2/ALX,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=223,O88536,Formyl peptide receptor 2,14289,Fpr2,10090,Mus musculus (house mouse),Full agonist,pEC50,6 - 7,PMID:15153530,https://www.ncbi.nlm.nih.gov/pubmed/15153530,15153530,,
43,1990715,16131438,IUPHAR/BPS Guide to PHARMACOLOGY,Humanin,1047,humanin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1047,224,FPR3,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=224,P25089,N-formyl peptide receptor 3,2359,FPR3,9606,Homo sapiens (human),Full agonist,pEC50,8.95,PMID:15465011,https://www.ncbi.nlm.nih.gov/pubmed/15465011,15465011,,
44,1990716,16132429,IUPHAR/BPS Guide to PHARMACOLOGY,Sarafotoxin 6c,1008,sarafotoxin S6c,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1008,220,ETB receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=220,P24530,Endothelin receptor type B,1910,EDNRB,9606,Homo sapiens (human),Full agonist,pKd,8.8 - 9.8,PMID:8904635|PMID:8587419,https://www.ncbi.nlm.nih.gov/pubmed/8904635|https://www.ncbi.nlm.nih.gov/pubmed/8587419,8904635|8587419,,
45,1990717,16132429,IUPHAR/BPS Guide to PHARMACOLOGY,Sarafotoxin 6c,1008,sarafotoxin S6c,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1008,220,ETB receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=220,P21451,Endothelin receptor type B,50672,Ednrb,10116,Rattus norvegicus (Norway rat),Full agonist,pKd,10.2 - 10.8,PMID:8904635|PMID:1850245,https://www.ncbi.nlm.nih.gov/pubmed/8904635|https://www.ncbi.nlm.nih.gov/pubmed/1850245,8904635|1850245,,
46,1990718,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,6868,ADAM17,https://ctdbase.org/detail.go?type=gene&acc=6868,,,6868,ADAM17,9606,Homo sapiens (human),Melitten results in increased cleavage of and results in increased activity of ADAM17 protein,,,PMID:22613720,https://www.ncbi.nlm.nih.gov/pubmed/22613720,22613720,,
47,1990719,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,60,ACTB,https://ctdbase.org/detail.go?type=gene&acc=60,,,60,ACTB,9606,Homo sapiens (human),Melitten results in increased expression of ACTB protein,,,PMID:34375656,https://www.ncbi.nlm.nih.gov/pubmed/34375656,34375656,,
48,1990720,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,102,ADAM10,https://ctdbase.org/detail.go?type=gene&acc=102,,,102,ADAM10,9606,Homo sapiens (human),Melitten results in increased cleavage of and results in increased activity of ADAM10 protein,,,PMID:22613720,https://www.ncbi.nlm.nih.gov/pubmed/22613720,22613720,,
49,1990721,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317,APAF1,10116,Rattus norvegicus (Norway rat),Melitten inhibits the reaction [[IL6 protein co-treated with IL6R protein] results in increased expression of APAF1 protein],,,PMID:21354845,https://www.ncbi.nlm.nih.gov/pubmed/21354845,21354845,,
50,1990722,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578,BAK1,9606,Homo sapiens (human),Melitten results in increased expression of BAK1 protein,,,PMID:34375656,https://www.ncbi.nlm.nih.gov/pubmed/34375656,34375656,,
51,1990723,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,9606,Homo sapiens (human),Melitten analog results in increased expression of BAX protein|melitten analog results in increased expression of BAX mRNA,,,PMID:29387245,https://www.ncbi.nlm.nih.gov/pubmed/29387245,29387245,,
52,1990724,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,9606,Homo sapiens (human),Melitten results in increased expression of BAX protein,,,PMID:22027265|PMID:34375656,https://www.ncbi.nlm.nih.gov/pubmed/22027265|https://www.ncbi.nlm.nih.gov/pubmed/34375656,22027265|34375656,,
53,1990725,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,10090,Mus musculus (house mouse),Melitten affects the reaction [TGFB1 protein affects the localization of BAX protein],,,PMID:21871910,https://www.ncbi.nlm.nih.gov/pubmed/21871910,21871910,,
54,1990735,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,9606,Homo sapiens (human),Melitten analog results in decreased expression of BCL2 mrna|melitten analog results in decreased expression of BCL2 protein,,,PMID:29387245,https://www.ncbi.nlm.nih.gov/pubmed/29387245,29387245,,
55,1990736,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,9606,Homo sapiens (human),Melitten results in decreased expression of BCL2 protein,,,PMID:21456063|PMID:22027265,https://www.ncbi.nlm.nih.gov/pubmed/21456063|https://www.ncbi.nlm.nih.gov/pubmed/22027265,21456063|22027265,,
56,1990737,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,10090,Mus musculus (house mouse),Melitten affects the reaction [TGFB1 protein affects the localization of BCL2 protein],,,PMID:21871910,https://www.ncbi.nlm.nih.gov/pubmed/21871910,21871910,,
57,1990738,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,10116,Rattus norvegicus (Norway rat),Melitten inhibits the reaction [[IL6 protein co-treated with IL6R protein] results in increased expression of BCL2 protein]|melitten inhibits the reaction [[IL6 protein co-treated with IL6R protein] results in increased expression of BCL2 mrna],,,PMID:21354845,https://www.ncbi.nlm.nih.gov/pubmed/21354845,21354845,,
58,1990739,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,330,BIRC3,https://ctdbase.org/detail.go?type=gene&acc=330,,,330,BIRC3,9606,Homo sapiens (human),Melitten results in decreased expression of BIRC3 protein,,,PMID:21456063,https://www.ncbi.nlm.nih.gov/pubmed/21456063,21456063,,
59,1990740,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,801,CALM1,https://ctdbase.org/detail.go?type=gene&acc=801,,,801,CALM1,10116,Rattus norvegicus (Norway rat),Melitten binds to CALM1 protein,,,PMID:17098364,https://www.ncbi.nlm.nih.gov/pubmed/17098364,17098364,,
60,1990741,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Melitten analog results in increased expression of CASP3 mrna|melitten analog results in increased expression of CASP3 protein,,,PMID:29387245,https://www.ncbi.nlm.nih.gov/pubmed/29387245,29387245,,
61,1990742,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Melitten results in decreased expression of CASP3 protein,,,PMID:34375656,https://www.ncbi.nlm.nih.gov/pubmed/34375656,34375656,,
62,1990743,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Melitten results in increased cleavage of and results in increased activity of CASP3 protein,,,PMID:21456063,https://www.ncbi.nlm.nih.gov/pubmed/21456063,21456063,,
63,1990744,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Melitten results in increased expression of CASP3 protein modified form,,,PMID:22027265,https://www.ncbi.nlm.nih.gov/pubmed/22027265,22027265,,
64,1990745,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,10090,Mus musculus (house mouse),Melitten inhibits the reaction [TGFB1 protein results in increased cleavage of CASP3 protein],,,PMID:21871910,https://www.ncbi.nlm.nih.gov/pubmed/21871910,21871910,,
65,1990746,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,10116,Rattus norvegicus (Norway rat),Melitten promotes the reaction [[IL6 protein co-treated with IL6R protein] results in increased expression of CASP3 mrna]|melitten promotes the reaction [[IL6 protein co-treated with IL6R protein] results in increased expression of and results in increased activity of CASP3 protein],,,PMID:21354845,https://www.ncbi.nlm.nih.gov/pubmed/21354845,21354845,,
66,1990747,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841,CASP8,9606,Homo sapiens (human),Melitten results in increased expression of CASP8 protein modified form,,,PMID:22027265,https://www.ncbi.nlm.nih.gov/pubmed/22027265,22027265,,
67,1990748,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842,CASP9,9606,Homo sapiens (human),Melitten analog results in increased expression of CASP9 protein|melitten analog results in increased expression of CASP9 mRNA,,,PMID:29387245,https://www.ncbi.nlm.nih.gov/pubmed/29387245,29387245,,
68,1990749,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842,CASP9,9606,Homo sapiens (human),Melitten results in increased cleavage of and results in increased activity of CASP9 protein,,,PMID:21456063,https://www.ncbi.nlm.nih.gov/pubmed/21456063,21456063,,
69,1990750,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842,CASP9,10090,Mus musculus (house mouse),Melitten inhibits the reaction [TGFB1 protein results in increased cleavage of CASP9 protein],,,PMID:21871910,https://www.ncbi.nlm.nih.gov/pubmed/21871910,21871910,,
70,1990751,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842,CASP9,10116,Rattus norvegicus (Norway rat),Melitten promotes the reaction [[IL6 protein co-treated with IL6R protein] results in increased expression of CASP9 protein]|melitten promotes the reaction [[IL6 protein co-treated with IL6R protein] results in increased expression of CASP9 mrna],,,PMID:21354845,https://www.ncbi.nlm.nih.gov/pubmed/21354845,21354845,,
71,1990752,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595,CCND1,9606,Homo sapiens (human),Melitten results in decreased expression of CCND1 protein,,,PMID:26189965,https://www.ncbi.nlm.nih.gov/pubmed/26189965,26189965,,
72,1990753,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999,CDH1,9606,Homo sapiens (human),Melitten results in increased secretion of CDH1 protein,,,PMID:22613720,https://www.ncbi.nlm.nih.gov/pubmed/22613720,22613720,,
73,1990754,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019,CDK4,9606,Homo sapiens (human),Melitten results in decreased expression of CDK4 protein,,,PMID:26189965,https://www.ncbi.nlm.nih.gov/pubmed/26189965,26189965,,
74,1990772,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,1082,CGB3,https://ctdbase.org/detail.go?type=gene&acc=1082,,,1082,CGB3,9606,Homo sapiens (human),GNRH1 protein results in increased susceptibility to [melitten binds to CGB3 protein]|lhcgr protein results in increased susceptibility to [melitten binds to CGB3 protein],,,PMID:19261682,https://www.ncbi.nlm.nih.gov/pubmed/19261682,19261682,,
75,1990773,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,1139,CHRNA7,https://ctdbase.org/detail.go?type=gene&acc=1139,,,1139,CHRNA7,10116,Rattus norvegicus (Norway rat),Methyllycaconitine inhibits the reaction [melitten results in increased activity of CHRNA7 protein]|bungarotoxins inhibits the reaction [melitten results in increased activity of CHRNA7 protein]|melitten results in increased activity of CHRNA7 protein,,,PMID:19910175,https://www.ncbi.nlm.nih.gov/pubmed/19910175,19910175,,
76,1990774,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,1147,CHUK,https://ctdbase.org/detail.go?type=gene&acc=1147,,,1147,CHUK,9605,Homo,Melitten inhibits the reaction [TNF protein results in increased activity of CHUK protein]|hydrogen peroxide inhibits the reaction [melitten inhibits the reaction [nitroprusside results in increased activity of CHUK protein]]|melitten inhibits the reaction [nitroprusside results in increased activity of CHUK protein]|glutathione inhibits the reaction [melitten binds to and results in decreased activity of CHUK protein]|melitten inhibits the reaction [lipopolysaccharides results in increased phosphorylation of and results in increased activity of CHUK protein]|melitten binds to CHUK protein|dithiothreitol inhibits the reaction [melitten inhibits the reaction [nitroprusside results in increased activity of CHUK protein]]|[melitten inhibits the reaction [nitroprusside results in increased phosphorylation of CHUK protein]] which results in decreased localization of NFKB1 protein|dithiothreitol inhibits the reaction [melitten binds to and results in decreased activity of CHUK protein]|glutathione inhibits the reaction [melitten inhibits the reaction [nitroprusside results in increased activity of CHUK protein]]|melitten inhibits the reaction [TNF protein results in increased phosphorylation of CHUK protein]|melitten inhibits the reaction [nitroprusside results in increased phosphorylation of and results in increased activity of CHUK protein]|melitten inhibits the reaction [nitroprusside results in increased phosphorylation of CHUK protein],,,PMID:17067557,https://www.ncbi.nlm.nih.gov/pubmed/17067557,17067557,,
77,1990775,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,1147,CHUK,https://ctdbase.org/detail.go?type=gene&acc=1147,,,1147,CHUK,10090,Mus musculus (house mouse),Melitten inhibits the reaction [thioacetamide results in increased phosphorylation of CHUK protein],,,PMID:21969711,https://www.ncbi.nlm.nih.gov/pubmed/21969711,21969711,,
78,1990776,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,1410,CRYAB,https://ctdbase.org/detail.go?type=gene&acc=1410,,,1410,CRYAB,10116,Rattus norvegicus (Norway rat),Melitten promotes the reaction [sodium arsenite results in increased expression of CRYAB protein]|melitten promotes the reaction [sodium arsenite results in increased expression of CRYAB mrna],,,PMID:8591993,https://www.ncbi.nlm.nih.gov/pubmed/8591993,8591993,,
79,1990777,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576,CXCL8,9606,Homo sapiens (human),Melitten results in increased expression of CXCL8 mRNA,,,PMID:17579088,https://www.ncbi.nlm.nih.gov/pubmed/17579088,17579088,,
80,1990778,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,1813,DRD2,https://ctdbase.org/detail.go?type=gene&acc=1813,,,1813,DRD2,9606,Homo sapiens (human),Melitten inhibits the reaction [spiperone binds to DRD2 protein],,,PMID:20969853,https://www.ncbi.nlm.nih.gov/pubmed/20969853,20969853,,
81,1990779,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956,EGFR,9606,Homo sapiens (human),Melitten results in increased activity of EGFR protein,,,PMID:22613720,https://www.ncbi.nlm.nih.gov/pubmed/22613720,22613720,,
82,1990789,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355,FAS,9606,Homo sapiens (human),Melitten results in increased expression of FAS mRNA,,,PMID:17854560,https://www.ncbi.nlm.nih.gov/pubmed/17854560,17854560,,
83,1990790,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355,FAS,9606,Homo sapiens (human),Melitten results in increased expression of FAS protein,,,PMID:16974113|PMID:17854560,https://www.ncbi.nlm.nih.gov/pubmed/16974113|https://www.ncbi.nlm.nih.gov/pubmed/17854560,16974113|17854560,,
84,1990791,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,2247,FGF2,https://ctdbase.org/detail.go?type=gene&acc=2247,,,2247,FGF2,9606,Homo sapiens (human),Melitten results in decreased expression of FGF2 mRNA,,,PMID:18076793,https://www.ncbi.nlm.nih.gov/pubmed/18076793,18076793,,
85,1990792,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335,FN1,10090,Mus musculus (house mouse),Melitten inhibits the reaction [thioacetamide results in increased expression of FN1 protein],,,PMID:21969711,https://www.ncbi.nlm.nih.gov/pubmed/21969711,21969711,,
86,1990793,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,2596,GAP43,https://ctdbase.org/detail.go?type=gene&acc=2596,,,2596,GAP43,10090,Mus musculus (house mouse),Melitten results in increased phosphorylation of GAP43 protein,,,PMID:9852580,https://www.ncbi.nlm.nih.gov/pubmed/9852580,9852580,,
87,1990794,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,100505592,GAPLINC,https://ctdbase.org/detail.go?type=gene&acc=100505592,,,100505592,GAPLINC,9606,Homo sapiens (human),Melitten results in increased expression of GAPLINC mRNA,,,PMID:34375656,https://www.ncbi.nlm.nih.gov/pubmed/34375656,34375656,,
88,1990795,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,2735,GLI1,https://ctdbase.org/detail.go?type=gene&acc=2735,,,2735,GLI1,9606,Homo sapiens (human),Melitten results in decreased expression of GLI1 protein,,,PMID:26189965,https://www.ncbi.nlm.nih.gov/pubmed/26189965,26189965,,
89,1990796,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,2796,GNRH1,https://ctdbase.org/detail.go?type=gene&acc=2796,,,2796,GNRH1,9606,Homo sapiens (human),GNRH1 protein results in increased susceptibility to [melitten binds to CGB3 protein],,,PMID:19261682,https://www.ncbi.nlm.nih.gov/pubmed/19261682,19261682,,
90,1990797,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,283120,H19,https://ctdbase.org/detail.go?type=gene&acc=283120,,,283120,H19,9606,Homo sapiens (human),Melitten results in decreased expression of H19 mRNA,,,PMID:34375656,https://www.ncbi.nlm.nih.gov/pubmed/34375656,34375656,,
91,1990798,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,3074,HEXB,https://ctdbase.org/detail.go?type=gene&acc=3074,,,3074,HEXB,9615,Canis lupus familiaris (dog),Trisialoganglioside GT1 inhibits the reaction [melitten results in increased secretion of HEXB protein]|g(m1) ganglioside inhibits the reaction [melitten results in increased secretion of HEXB protein]|melitten results in increased secretion of HEXB protein|sialogangliosides inhibits the reaction [melitten results in increased secretion of HEXB protein],,,PMID:21334356,https://www.ncbi.nlm.nih.gov/pubmed/21334356,21334356,,
92,1990809,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,3274,HRH2,https://ctdbase.org/detail.go?type=gene&acc=3274,,,3274,HRH2,10116,Rattus norvegicus (Norway rat),Ranitidine inhibits the reaction [melitten results in increased activity of HRH2 protein]|hrh2 protein results in increased susceptibility to melitten|melitten results in increased activity of HRH2 protein,,,PMID:22995146,https://www.ncbi.nlm.nih.gov/pubmed/22995146,22995146,,
93,1990810,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,3350,HTR1A,https://ctdbase.org/detail.go?type=gene&acc=3350,,,3350,HTR1A,9606,Homo sapiens (human),Melitten inhibits the reaction [HTR1A protein inhibits the reaction [colforsin results in increased abundance of cyclic AMP]],,,PMID:11356925,https://www.ncbi.nlm.nih.gov/pubmed/11356925,11356925,,
94,1990811,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383,ICAM1,9606,Homo sapiens (human),Melitten results in decreased expression of ICAM1 protein,,,PMID:12697458,https://www.ncbi.nlm.nih.gov/pubmed/12697458,12697458,,
95,1990812,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,3551,IKBKB,https://ctdbase.org/detail.go?type=gene&acc=3551,,,3551,IKBKB,9606,Homo sapiens (human),Melitten binds to IKBKB protein|melitten inhibits the reaction [nitroprusside results in increased activity of IKBKB protein]|melitten inhibits the reaction [lipopolysaccharides results in increased activity of IKBKB protein]|dithiothreitol inhibits the reaction [melitten binds to and results in decreased activity of IKBKB protein]|hydrogen peroxide inhibits the reaction [melitten inhibits the reaction [nitroprusside results in increased activity of IKBKB protein]]|glutathione inhibits the reaction [melitten binds to and results in decreased activity of IKBKB protein]|glutathione inhibits the reaction [melitten inhibits the reaction [nitroprusside results in increased activity of IKBKB protein]]|dithiothreitol inhibits the reaction [melitten inhibits the reaction [nitroprusside results in increased activity of IKBKB protein]]|melitten inhibits the reaction [TNF protein results in increased activity of IKBKB protein],,,PMID:17067557,https://www.ncbi.nlm.nih.gov/pubmed/17067557,17067557,,
96,1990813,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,3606,IL18,https://ctdbase.org/detail.go?type=gene&acc=3606,,,3606,IL18,9606,Homo sapiens (human),AIM2 protein promotes the reaction [melitten results in increased expression of IL18 protein]|melitten results in increased expression of IL18 protein,,,PMID:22973906,https://www.ncbi.nlm.nih.gov/pubmed/22973906,22973906,,
97,1990814,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,9606,Homo sapiens (human),AIM2 protein promotes the reaction [melitten results in increased expression of IL1B protein]|melitten results in increased expression of IL1B protein,,,PMID:22973906,https://www.ncbi.nlm.nih.gov/pubmed/22973906,22973906,,
98,1990815,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,10090,Mus musculus (house mouse),Melitten inhibits the reaction [lipopolysaccharides results in increased expression of IL1B mrna],,,PMID:17570326,https://www.ncbi.nlm.nih.gov/pubmed/17570326,17570326,,
99,1990816,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,10116,Rattus norvegicus (Norway rat),Melitten inhibits the reaction [TNF protein results in increased expression of IL1B protein],,,PMID:21969711,https://www.ncbi.nlm.nih.gov/pubmed/21969711,21969711,,
100,1990817,16133648,Comparative Toxicogenomics Database (CTD),Forapin,D008555,Melitten,https://ctdbase.org/detail.go?type=chem&acc=D008555,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565,IL4,9823,Sus scrofa (pig),IL4 protein results in decreased susceptibility to melitten,,,PMID:20017192,https://www.ncbi.nlm.nih.gov/pubmed/20017192,20017192,,
101,1990655,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,7086,TKT,https://ctdbase.org/detail.go?type=gene&acc=7086,,,7086,TKT,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TKT mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
102,1990656,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,219902,TLCD5,https://ctdbase.org/detail.go?type=gene&acc=219902,,,219902,TLCD5,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TLCD5 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
103,1990657,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,219902,TLCD5,https://ctdbase.org/detail.go?type=gene&acc=219902,,,219902,TLCD5,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TLCD5 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
104,1990658,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,7090,TLE3,https://ctdbase.org/detail.go?type=gene&acc=7090,,,7090,TLE3,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TLE3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
105,1990659,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,7090,TLE3,https://ctdbase.org/detail.go?type=gene&acc=7090,,,7090,TLE3,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TLE3 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
106,1990660,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,7091,TLE4,https://ctdbase.org/detail.go?type=gene&acc=7091,,,7091,TLE4,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TLE4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
107,1990661,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,7091,TLE4,https://ctdbase.org/detail.go?type=gene&acc=7091,,,7091,TLE4,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TLE4 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
108,1990662,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,11011,TLK2,https://ctdbase.org/detail.go?type=gene&acc=11011,,,11011,TLK2,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TLK2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
109,1990663,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,11011,TLK2,https://ctdbase.org/detail.go?type=gene&acc=11011,,,11011,TLK2,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TLK2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
110,1990664,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,7093,TLL2,https://ctdbase.org/detail.go?type=gene&acc=7093,,,7093,TLL2,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TLL2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
111,1990665,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,7093,TLL2,https://ctdbase.org/detail.go?type=gene&acc=7093,,,7093,TLL2,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TLL2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
112,1990666,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,7098,TLR3,https://ctdbase.org/detail.go?type=gene&acc=7098,,,7098,TLR3,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TLR3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
113,1990667,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,7099,TLR4,https://ctdbase.org/detail.go?type=gene&acc=7099,,,7099,TLR4,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TLR4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
114,1990668,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,7099,TLR4,https://ctdbase.org/detail.go?type=gene&acc=7099,,,7099,TLR4,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TLR4 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
115,1990669,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,80213,TM2D3,https://ctdbase.org/detail.go?type=gene&acc=80213,,,80213,TM2D3,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TM2D3 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
116,1990670,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,4071,TM4SF1,https://ctdbase.org/detail.go?type=gene&acc=4071,,,4071,TM4SF1,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TM4SF1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
117,1990671,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,4071,TM4SF1,https://ctdbase.org/detail.go?type=gene&acc=4071,,,4071,TM4SF1,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TM4SF1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
118,1990672,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,116441,TM4SF18,https://ctdbase.org/detail.go?type=gene&acc=116441,,,116441,TM4SF18,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TM4SF18 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
119,1990673,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,116441,TM4SF18,https://ctdbase.org/detail.go?type=gene&acc=116441,,,116441,TM4SF18,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TM4SF18 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
120,1990674,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,51768,TM7SF3,https://ctdbase.org/detail.go?type=gene&acc=51768,,,51768,TM7SF3,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TM7SF3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
121,1990675,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,51768,TM7SF3,https://ctdbase.org/detail.go?type=gene&acc=51768,,,51768,TM7SF3,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TM7SF3 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
122,1990676,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,7009,TMBIM6,https://ctdbase.org/detail.go?type=gene&acc=7009,,,7009,TMBIM6,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMBIM6 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
123,1990677,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,7009,TMBIM6,https://ctdbase.org/detail.go?type=gene&acc=7009,,,7009,TMBIM6,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TMBIM6 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
124,1990678,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,79838,TMC5,https://ctdbase.org/detail.go?type=gene&acc=79838,,,79838,TMC5,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMC5 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
125,1990679,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,79838,TMC5,https://ctdbase.org/detail.go?type=gene&acc=79838,,,79838,TMC5,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TMC5 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
126,1990680,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,11322,TMC6,https://ctdbase.org/detail.go?type=gene&acc=11322,,,11322,TMC6,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMC6 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
127,1990681,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,11322,TMC6,https://ctdbase.org/detail.go?type=gene&acc=11322,,,11322,TMC6,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TMC6 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
128,1990682,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,79905,TMC7,https://ctdbase.org/detail.go?type=gene&acc=79905,,,79905,TMC7,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMC7 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
129,1990683,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,79905,TMC7,https://ctdbase.org/detail.go?type=gene&acc=79905,,,79905,TMC7,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TMC7 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
130,1990684,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,57458,TMCC3,https://ctdbase.org/detail.go?type=gene&acc=57458,,,57458,TMCC3,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMCC3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
131,1990685,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,57458,TMCC3,https://ctdbase.org/detail.go?type=gene&acc=57458,,,57458,TMCC3,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TMCC3 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
132,1990686,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,55002,TMCO3,https://ctdbase.org/detail.go?type=gene&acc=55002,,,55002,TMCO3,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMCO3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
133,1990687,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,55002,TMCO3,https://ctdbase.org/detail.go?type=gene&acc=55002,,,55002,TMCO3,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TMCO3 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
134,1990688,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,100652857,TMCO5B,https://ctdbase.org/detail.go?type=gene&acc=100652857,,,100652857,TMCO5B,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMCO5B mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
135,1990698,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,100652857,TMCO5B,https://ctdbase.org/detail.go?type=gene&acc=100652857,,,100652857,TMCO5B,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TMCO5B mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
136,1990699,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,55374,TMCO6,https://ctdbase.org/detail.go?type=gene&acc=55374,,,55374,TMCO6,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMCO6 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
137,1990700,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,55374,TMCO6,https://ctdbase.org/detail.go?type=gene&acc=55374,,,55374,TMCO6,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TMCO6 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
138,1990701,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,50999,TMED5,https://ctdbase.org/detail.go?type=gene&acc=50999,,,50999,TMED5,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMED5 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
139,1990702,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,50999,TMED5,https://ctdbase.org/detail.go?type=gene&acc=50999,,,50999,TMED5,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TMED5 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
140,1990703,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,283578,TMED8,https://ctdbase.org/detail.go?type=gene&acc=283578,,,283578,TMED8,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMED8 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
141,1990704,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,283578,TMED8,https://ctdbase.org/detail.go?type=gene&acc=283578,,,283578,TMED8,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TMED8 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
142,1990705,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,23671,TMEFF2,https://ctdbase.org/detail.go?type=gene&acc=23671,,,23671,TMEFF2,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEFF2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
143,1990706,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,23671,TMEFF2,https://ctdbase.org/detail.go?type=gene&acc=23671,,,23671,TMEFF2,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TMEFF2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
144,1990726,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,66000,TMEM108,https://ctdbase.org/detail.go?type=gene&acc=66000,,,66000,TMEM108,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM108 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
145,1990727,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,66000,TMEM108,https://ctdbase.org/detail.go?type=gene&acc=66000,,,66000,TMEM108,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TMEM108 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
146,1990728,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,84216,TMEM117,https://ctdbase.org/detail.go?type=gene&acc=84216,,,84216,TMEM117,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM117 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
147,1990729,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,84216,TMEM117,https://ctdbase.org/detail.go?type=gene&acc=84216,,,84216,TMEM117,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TMEM117 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
148,1990730,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,83862,TMEM120A,https://ctdbase.org/detail.go?type=gene&acc=83862,,,83862,TMEM120A,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM120A mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
149,1990731,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,83862,TMEM120A,https://ctdbase.org/detail.go?type=gene&acc=83862,,,83862,TMEM120A,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TMEM120A mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
150,1990732,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,27439,TMEM121B,https://ctdbase.org/detail.go?type=gene&acc=27439,,,27439,TMEM121B,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM121B mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
151,1990733,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,27439,TMEM121B,https://ctdbase.org/detail.go?type=gene&acc=27439,,,27439,TMEM121B,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TMEM121B mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
152,1990734,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,114795,TMEM132B,https://ctdbase.org/detail.go?type=gene&acc=114795,,,114795,TMEM132B,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM132B mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
153,1990763,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,114795,TMEM132B,https://ctdbase.org/detail.go?type=gene&acc=114795,,,114795,TMEM132B,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TMEM132B mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
154,1990764,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,124842,TMEM132E,https://ctdbase.org/detail.go?type=gene&acc=124842,,,124842,TMEM132E,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM132E mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
155,1990765,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,124842,TMEM132E,https://ctdbase.org/detail.go?type=gene&acc=124842,,,124842,TMEM132E,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TMEM132E mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
156,1990766,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,55314,TMEM144,https://ctdbase.org/detail.go?type=gene&acc=55314,,,55314,TMEM144,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM144 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
157,1990767,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,55314,TMEM144,https://ctdbase.org/detail.go?type=gene&acc=55314,,,55314,TMEM144,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TMEM144 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
158,1990768,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,441027,TMEM150C,https://ctdbase.org/detail.go?type=gene&acc=441027,,,441027,TMEM150C,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM150C mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
159,1990769,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,441027,TMEM150C,https://ctdbase.org/detail.go?type=gene&acc=441027,,,441027,TMEM150C,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TMEM150C mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
160,1990770,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,201799,TMEM154,https://ctdbase.org/detail.go?type=gene&acc=201799,,,201799,TMEM154,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM154 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
161,1990771,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,201799,TMEM154,https://ctdbase.org/detail.go?type=gene&acc=201799,,,201799,TMEM154,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TMEM154 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
162,1990780,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,25907,TMEM158,https://ctdbase.org/detail.go?type=gene&acc=25907,,,25907,TMEM158,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM158 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
163,1990781,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,25907,TMEM158,https://ctdbase.org/detail.go?type=gene&acc=25907,,,25907,TMEM158,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TMEM158 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
164,1990782,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,100505894,TMEM161B-DT,https://ctdbase.org/detail.go?type=gene&acc=100505894,,,100505894,TMEM161B-DT,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM161B-DT mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
165,1990783,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,100505894,TMEM161B-DT,https://ctdbase.org/detail.go?type=gene&acc=100505894,,,100505894,TMEM161B-DT,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TMEM161B-DT mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
166,1990784,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,81615,TMEM163,https://ctdbase.org/detail.go?type=gene&acc=81615,,,81615,TMEM163,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM163 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
167,1990785,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,81615,TMEM163,https://ctdbase.org/detail.go?type=gene&acc=81615,,,81615,TMEM163,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TMEM163 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
168,1990786,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,92691,TMEM169,https://ctdbase.org/detail.go?type=gene&acc=92691,,,92691,TMEM169,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM169 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
169,1990787,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,92691,TMEM169,https://ctdbase.org/detail.go?type=gene&acc=92691,,,92691,TMEM169,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TMEM169 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
170,1990788,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,129787,TMEM18,https://ctdbase.org/detail.go?type=gene&acc=129787,,,129787,TMEM18,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM18 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
171,1990799,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,129787,TMEM18,https://ctdbase.org/detail.go?type=gene&acc=129787,,,129787,TMEM18,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TMEM18 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
172,1990800,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,55287,TMEM40,https://ctdbase.org/detail.go?type=gene&acc=55287,,,55287,TMEM40,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TMEM40 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
173,1990801,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,79134,TMEM185B,https://ctdbase.org/detail.go?type=gene&acc=79134,,,79134,TMEM185B,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM185B mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
174,1990802,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,79134,TMEM185B,https://ctdbase.org/detail.go?type=gene&acc=79134,,,79134,TMEM185B,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TMEM185B mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
175,1990803,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,645369,TMEM200C,https://ctdbase.org/detail.go?type=gene&acc=645369,,,645369,TMEM200C,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM200C mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
176,1990804,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,645369,TMEM200C,https://ctdbase.org/detail.go?type=gene&acc=645369,,,645369,TMEM200C,9606,Homo sapiens (human),Phenylmercuric acetate results in increased expression of TMEM200C mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
177,1990805,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,84928,TMEM209,https://ctdbase.org/detail.go?type=gene&acc=84928,,,84928,TMEM209,9606,Homo sapiens (human),"[NOG protein co-treated with phenylmercuric acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM209 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
178,1990806,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,84928,TMEM209,https://ctdbase.org/detail.go?type=gene&acc=84928,,,84928,TMEM209,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TMEM209 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
179,1990807,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,219854,TMEM218,https://ctdbase.org/detail.go?type=gene&acc=219854,,,219854,TMEM218,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TMEM218 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
180,1990808,16682730,Comparative Toxicogenomics Database (CTD),Phenylmercuric acetate,D010662,Phenylmercuric Acetate,https://ctdbase.org/detail.go?type=chem&acc=D010662,100130519,TMEM221,https://ctdbase.org/detail.go?type=gene&acc=100130519,,,100130519,TMEM221,9606,Homo sapiens (human),Phenylmercuric acetate results in decreased expression of TMEM221 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
